Literature DB >> 28401259

Mechanism of salinomycin overproduction in Streptomyces albus as revealed by comparative functional genomics.

Xiaojie Zhang1, Chenyang Lu1,2, Linquan Bai3.   

Abstract

The anticoccidial salinomycin is a polyketide produced by Streptomyces albus, and the high-yield strain BK 3-25 produces 18.0 g/L salinomycin under lab condition. In order to elucidate the overproduction mechanism, the genome of BK 3-25 was fully sequenced and compared with the wild-type DSM 41398. Strain BK 3-25 has a 75-kb large deletion, containing type-I polyketide gene cluster PKS-9, and 60 additional InDels and SNVs affecting 55 CDSs, including a 1-bp deletion in type-I PKS gene cluster PKS-6. Subsequently, individual or combined deletions of the 75-kb region and PKS-6 in the wild-type resulted in improved salinomycin yields from 2.60 to 5.20, 6.90, and 9.50 g/L (53% of BK 3-25), respectively, suggesting a redirected flux of polyketide precursors to salinomycin biosynthesis. Moreover, due to the much higher transcription of salinomycin biosynthetic genes (sln) in the high-yield BK 3-25 than in the wild-type, 13 putative regulatory genes among the 55 CDSs were individually inactivated and 7 were proved to be negatively involved in the transcription of sln genes. Combined deletions of two major negative regulatory genes SLNWT_3357 and SLNWT_7015 caused further improved transcription of sln genes as well as the yield, from 2.60 to 7.30 g/L (40% of BK 3-25). Therefore, the comparative genomics approach combined with functional experiments identified that the multiple deletions and mutations of competing gene clusters and negative regulatory genes are crucial for salinomycin overproduction, setting an example for rational titer improvement of other polyketide natural products.

Entities:  

Keywords:  Comparative genomics; Overproduction; Polyketide; Regulation; Salinomycin

Mesh:

Substances:

Year:  2017        PMID: 28401259     DOI: 10.1007/s00253-017-8278-5

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  7 in total

1.  Genomics-driven discovery of the biosynthetic gene cluster of maduramicin and its overproduction in Actinomadura sp. J1-007.

Authors:  Ran Liu; Fang Fang; Ziheng An; Renqiong Huang; Yong Wang; Xiao Sun; Shuai Fu; Aisi Fu; Zixin Deng; Tiangang Liu
Journal:  J Ind Microbiol Biotechnol       Date:  2019-12-18       Impact factor: 3.346

2.  Efflux identification and engineering for ansamitocin P-3 production in Actinosynnema pretiosum.

Authors:  Xinran Wang; Jianhua Wei; Yifan Xiao; Shuhui Luan; Xinjuan Ning; Linquan Bai
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

3.  Comparative Transcriptome-Based Mining of Genes Involved in the Export of Polyether Antibiotics for Titer Improvement.

Authors:  Xian Liu; Yuanting Wu; Xiaojie Zhang; Qianjin Kang; Yusi Yan; Linquan Bai
Journal:  Antibiotics (Basel)       Date:  2022-04-29

4.  Subtilisin-Involved Morphology Engineering for Improved Antibiotic Production in Actinomycetes.

Authors:  Yuanting Wu; Qianjin Kang; Li-Li Zhang; Linquan Bai
Journal:  Biomolecules       Date:  2020-06-03

5.  Comparative functional genomics of the acarbose producers reveals potential targets for metabolic engineering.

Authors:  Huixin Xie; Qinqin Zhao; Xin Zhang; Qianjin Kang; Linquan Bai
Journal:  Synth Syst Biotechnol       Date:  2019-01-18

6.  Complete genome sequence of high-yield strain S. lincolnensis B48 and identification of crucial mutations contributing to lincomycin overproduction.

Authors:  Ruida Wang; Fanjing Kong; Haizhen Wu; Bingbing Hou; Yajing Kang; Yuan Cao; Shiwei Duan; Jiang Ye; Huizhan Zhang
Journal:  Synth Syst Biotechnol       Date:  2020-04-13

7.  Reconstitution of a mini-gene cluster combined with ribosome engineering led to effective enhancement of salinomycin production in Streptomyces albus.

Authors:  Dong Li; Yuqing Tian; Xiang Liu; Wenxi Wang; Yue Li; Huarong Tan; Jihui Zhang
Journal:  Microb Biotechnol       Date:  2020-12-03       Impact factor: 5.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.